XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating Activities    
Net loss $ (115,298) $ (10,575)
Adjustments to reconcile net loss to operating activities:    
Amortization, depreciation and write-offs 128,989 88,817
Amortization of debt issuance costs and discount 3,246 4,303
Stock-based compensation 44,640 29,959
Change in operating right-of-use asset 5,751 5,796
Loss on settlement of debt 0 16,852
Net unrealized gains (losses) on fair value remeasurements 957 (11,214)
Net gain on foreign currency remeasurement (457) (1,305)
Changes in operating assets and liabilities:    
Accounts receivable (170,250) (43,917)
Prepaid expenses and other current assets (54,461) (18,775)
Other assets 1,098 472
Accounts payable 111,604 9,370
Operating lease liabilities (6,046) (5,631)
Accrued and other liabilities 21,138 (1,339)
Deferred revenue (2,630) (994)
Net cash provided by (used in) operating activities (31,719) 61,819
Investing Activities    
Purchase of property and equipment (285) (121)
Acquisitions, net of cash acquired (1,045,816) (4,152)
Purchase of non-marketable investments and other (14,146) (14,000)
Proceeds from other investing activities 2,162 0
Capitalized software development costs (1,658) 0
Net cash used in investing activities (1,059,743) (18,273)
Financing Activities    
Proceeds from debt issuance, net of issuance costs 0 844,729
Payments of debt principal (4,577) (302,327)
Payments of finance leases (6,176) (840)
Proceeds from exercise of stock options 8,110 12,882
Payments of deferred acquisition costs (1,710) (152,245)
Payments of licensed asset obligation (17,374) 0
Repurchases of stock - repurchase program (43,697) 0
Payments of deferred IPO costs 0 (1,825)
Net cash provided by (used in) financing activities (65,424) 400,374
Effect of foreign exchange rate on cash and cash equivalents (362) (80)
Net increase (decrease) in cash and cash equivalents (1,157,248) 443,840
Cash and cash equivalents at beginning of the period 2,570,504 317,235
Cash and cash equivalents at end of the period 1,413,256 761,075
Supplemental non-cash investing and financing activities disclosures:    
Acquisitions not yet paid 28,995 32,161
Assets acquired under finance leases 8,703 445
Deferred IPO costs not yet paid 0 1,834
Supplemental disclosure of cash flow information:    
Cash paid for interest on debt 28,865 15,662
Cash paid for income taxes $ 4,411 $ 221